Inflammation and steatosis differentially modulate antiviral efficacy in chronic hepatitis B with metabolic dysfunction-associated steatotic liver disease
World Journal of Gastroenterology · 17.06.2026
DOI: 10.3748/wjg.122545 ↗Kurz gefasst
Fachartikel in der Zeitschrift World Journal of Gastroenterology, online erschienen am 17.06.2026. Verfasst von Ming-Hui Zeng und 11 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Zeng, M., Tian, F., Hu, S., Han, J., Xu, L., Chu, L., Kuai, W., Li, Y., Wang, Y., Mi, Y., Zheng, M., & Xu, L. (2026). Inflammation and steatosis differentially modulate antiviral efficacy in chronic hepatitis B with metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology. https://doi.org/10.3748/wjg.122545
Vancouver
Zeng M, Tian F, Hu S, Han J, Xu L, Chu L, et al. Inflammation and steatosis differentially modulate antiviral efficacy in chronic hepatitis B with metabolic dysfunction-associated steatotic liver disease. World Journal of Gastroenterology. 2026. doi:10.3748/wjg.122545
BibTeX
@article{Zeng2026,
author = {Zeng, Ming-Hui and Tian, Fang-Yuan and Hu, Shi-Yun and Han, Jia-Xin and Xu, Lian-Xin and Chu, Li and Kuai, Wen-Tao and Li, Yu-Qin and Wang, Yi-Chen and Mi, Yu-Qiang and Zheng, Ming-Hua and Xu, Liang},
title = {Inflammation and steatosis differentially modulate antiviral efficacy in chronic hepatitis B with metabolic dysfunction-associated steatotic liver disease},
journal = {World Journal of Gastroenterology},
year = {2026},
doi = {10.3748/wjg.122545}
}
EUVIMED